Prevalence of Vitreomacular Adhesion in Patients 40 Years and Older
VAST
Phase 1 Study of Optical Coherence Tomography Images to Identify the Prevalence of Vitreomacular Adhesion and Associated Maculopathies
1 other identifier
observational
1,584
1 country
18
Brief Summary
The purpose of this study is to evaluate the prevalence of vitreomacular adhesion (VMA) in patients 40 years and older using Spectral Domain Optical Coherence Tomography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2014
Typical duration for all trials
18 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 2, 2014
CompletedFirst Posted
Study publicly available on registry
June 10, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2017
CompletedMarch 29, 2018
March 1, 2018
1.7 years
June 2, 2014
March 27, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
What is the overall prevalence of Vitreomacular adhesion in the population 40 years and older?
Prevalence will be measured using Spectral Domain Optical Coherence Tomography. Tomography scans will be evaluated for the presence or absence of vitreomacular adhesion.
Two years
Secondary Outcomes (1)
Is there is a significant correlation between VMA and various maculopathies including diabetic macular edema, retinal vascular occlusion, and age-related macular degeneration?
2 years
Other Outcomes (1)
Is VMA more common in males or females?
2 years
Study Arms (1)
Vitreomacular adhesion
Male or female subjects aged over 40 years with vitreomacular adhesion
Eligibility Criteria
Subjects will be selected from primary eye care clinics within academic settings, tertiary care clinics, and veterans administration medical centers.
You may qualify if:
- Clear media
You may not qualify if:
- Prior history of vitreoretinal surgery or pharmacotherapy with intravitreal injection
- Dense media opacity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nova Southeastern Universitylead
- ThromboGenicscollaborator
- Carl Zeiss Meditec, Inc.collaborator
- Optovuecollaborator
Study Sites (18)
Schaeffer Eye Center
Birmingham, Alabama, 35216, United States
Leo Semes
Birmingham, Alabama, 35294, United States
Schwartz Laser Eye Center
Scottsdale, Arizona, 85260, United States
VA Greater Los Angeles Healthcare System
Sepulveda, California, 91343, United States
Front Range Eye Associates
Broomfield, Colorado, 80023, United States
Aran Eye Associates
Coral Gables, Florida, 33134, United States
Nova Southeastern University
Fort Lauderdale, Florida, 33328, United States
Retina Macula Specialists of Miami
Miami, Florida, 33126, United States
Murray Ocular Oncology and Retina
Miami, Florida, 33143, United States
Vitreous and Retina Consultants
Winter Haven, Florida, 33880, United States
Clayton Eye Center
Morrow, Georgia, 30260, United States
Indiana University College of Optometry
Indianapolis, Indiana, 46202, United States
Grin Eyecare
Olathe, Kansas, 66061, United States
Jones Eyecare
Albuquerque, New Mexico, 87111, United States
Pacific University College of Optometry
Portland, Oregon, 97205, United States
Larry Alexander
McKinney, Texas, 75070, United States
Retina and Macula Specialists
Tacoma, Washington, 98409, United States
Suburban Opticians
University Place, Washington, 98466, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Julie A Rodman, OD, MS, FAAO
Nova Southeastern University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 2, 2014
First Posted
June 10, 2014
Study Start
May 1, 2014
Primary Completion
January 1, 2016
Study Completion
May 1, 2017
Last Updated
March 29, 2018
Record last verified: 2018-03